And The Hits Just Keep On Coming: Another Class I Recall For Philips Breathing Devices
The US FDA has designated another recall of Philips breathing devices as class I, its most serious type. The recall includes about a thousand devices that had previously been reworked during a June 2021 initial recall.
You may also be interested in...
The US FDA says the number of replacement sleep apnea devices Philips sent to customers as part of its ongoing recall was significantly less than the company claimed.
After an admittedly difficult 2022 for a variety of reasons, Philips Healthcare is ready to tackle 2023 and beyond by reducing business complexities, slimming staff numbers further and crucially implementing a new value creation strategy under recently appointed CEO Roy Jakobs.
The US FDA on 22 July designated a recent recall by Royal Philips of certain bi-level positive airway pressure (BiPAP), continuous positive airway pressure (CPAP), and other mechanical ventilator devices as high-risk class I.